Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

262 results about "Correction technique" patented technology

Quantum cryptography

A method of establishing a shared secret random cryptographic key between a sender and a recipient using a quantum communications channel is described. The method comprises: generating a plurality of random quantum states of a quantum entity, each random state being defined by a randomly selected one of a first plurality of bases in Hilbert space, transmitting the plurality of random quantum states of the quantum entity via the quantum channel to a recipient, measuring the quantum state of each of the received quantum states of the quantum entity with respect to a randomly selected one of a second plurality of bases in Hilbert space, transmitting to the recipient composition information describing a subset of the plurality of random quantum states, analysing the received composition information and the measured quantum states corresponding to the subset to derive a first statistical distribution describing the subset of transmitted quantum states and a second statistical distribution describing the corresponding measured quantum states, establishing the level of confidence in the validity of the plurality of transmitted random quantum states by verifying that the first and second statistical distributions are sufficiently similar, deriving a first binary sting and a second binary string, correlated to the first binary string, respectively from the transmitted and received plurality of quantum states not in the subset, and carrying out a reconciliation of the second binary string to the first binary string by using error correction techniques to establish the shared secret random cryptographic key from the first and second binary strings.
Owner:HEWLETT-PACKARD ENTERPRISE DEV LP +1

Determination of a measure of a glycation end-product or disease state using tissue fluorescence

A method of determining a measure of a tissue state (e.g., glycation end-product or disease state) in an individual. A portion of the tissue of the individual is illuminated with excitation light, then light emitted by the tissue due to fluorescence of a chemical with the tissue responsive to the excitation light is detected. The detected light can be combined with a model relating fluorescence with a measure of tissue state to determine a tissue state. The invention can comprise single wavelength excitation light, scanning of excitation light (illuminating the tissue at a plurality of wavelengths), detection at a single wavelength, scanning of detection wavelengths (detecting emitted light at a plurality of wavelengths), and combinations thereof. The invention also can comprise correction techniques that reduce determination errors due to detection of light other than that from fluorescence of a chemical in the tissue. For example, the reflectance of the tissue can lead to errors if appropriate correction is not employed. The invention can also comprise a variety of models relating fluorescence to a measure of tissue state, including a variety of methods for generating such models. Other biologic information can be used in combination with the fluorescence properties to aid in the determination of a measure of tissue state. The invention also comprises apparatuses suitable for carrying out the method, including appropriate light sources, detectors, and models (for example, implemented on computers) used to relate detected fluorescence and a measure of tissue state.
Owner:VERALIGHT INC

Method and apparatus for implementing beam forming in cdma communication system

The present invention relates to a device for realizing beam-forming in CDMA mobile telecommunication system by employing smart antenna technique and method thereof, which forms multiple fixed beams in a sector, and uses multiple fixed beams to form the traffic channel with narrow beams and the common channel with sector beams simultaneously in the same smart antenna system, and overcomes the problem of inconsistency of phrases of respective channels due to the variations of time and temperature without complicated correction technique, thereby improving the capacity and performance of CDMA system with multiple antennas. It solves the problem that the fixed beams in some area correlate with and counteract one another or are greatly reduced due to the correlating addition of the space vectors of each fixed beam when the multiple antenna CDMA system transmits the common channels, and makes the strength of the pilot channel and the traffic channel in corresponding proportion in the coverage area, and improves the signal to noise ratio of receiving signals by the mobile station. By adding an optical transceiver system between the base band and the radio frequency TRX, the base band part can support more sectors. The radio frequency part is very close to the antennas, therefore the power consumption is reduced.
Owner:ZTE CORP

Apparatuses for Noninvasive Determination of in vivo Alcohol Concentration using Raman Spectroscopy

Methods and apparatuses for the determination of an attribute of the tissue of an individual use non-invasive Raman spectroscopy. For example, the alcohol concentration in the blood or tissue of an individual can be determined non-invasively. A portion of the tissue is illuminated with light, the light propagates into the tissue where it is Raman scattered within the tissue. The Raman scattered light is then detected and can be combined with a model relating Raman spectra to alcohol concentration in order to determine the alcohol concentration in the blood or tissue of the individual. Correction techniques can be used to reduce determination errors due to detection of light other than that from Raman scattering from the alcohol in the tissue. Other biologic information can be used in combination with the Raman spectral properties to aid in the determination of alcohol concentration, for example age of the individual, height of the individual, weight of the individual, medical history of the individual and his/her family, ethnicity, skin melanin content, or a combination thereof. The method and apparatus can be highly optimized to provide reproducible and, preferably, uniform radiance of the tissue, low tissue sampling error, depth targeting of the tissue layers or sample locations that contain the attribute of interest, efficient collection of Raman spectra from the tissue, high optical throughput, high photometric accuracy, large dynamic range, excellent thermal stability, effective calibration maintenance, effective calibration transfer, built-in quality control, and ease-of-use.
Owner:ROCKLEY PHOTONICS LTD

Stereo display of tube-like structures and improved techniques therefor ("stereo display")

Improved systems and methods for stereoscopically displaying and virtually viewing tube-like anatomical structures are presented. Stereoscopic display of such structures can provide a user with better depth perception of the structure being viewed and thus make a virtual examination more real. In exemplary embodiments according to the present invention, ray shooting, coupled with appropriate error correction techniques, can be utilized for dynamic adjustment of an eye convergence point for stereo display. In exemplary embodiments of the present invention, the correctness of a convergence point can be verified to avoid a distractive and uncomfortable visualization. Additionally, in exemplary embodiments of the present invention, convergence points in consecutive time frames can be compared. If rapid changes are detected, the system can compensate by interpolating transitional convergence points. In exemplary embodiments according to the present invention ray shooting can also be utilized to display occluded areas behind folds and protrusions in the inner colon wall. In exemplary embodiments according to the present invention, interactive display control functionalities can be mapped to a gaming-type joystick or other three-dimensional controller, freeing thereby a user from the limits of a two-dimensional computer interface device such as a standard mouse or trackball.
Owner:BRACCO IMAGINIG SPA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products